Absci Corporation, a data-first generative AI drug creation company, announced the initiation of IND-enabling studies for ABS-101, a potential best-in-class anti-TL1A antibody designed using...
Saama announced the appointment of Bhaskar Sambasivan as Chief Executive Officer. Sambasivan succeeds Vivek Sharma, who is stepping down from his role for personal...
Perimeter Medical Imaging AI, Inc., a commercial-stage medical technology company – provided an update on the clinical development of its ongoing clinical trial evaluating...